Supreme Court Grants Cert In Drugmakers Patent Enablement Row
WASHINGTON, D.C. — A petition for writ of certiorari by Amgen Inc., whose patents associated with the monoclonal antibody drug “Repatha” were declared invalid by a Delaware federal judge for lack...To view the full article, register now.
Already a subscriber? Click here to view full article